ACR Convergence 2026 has ended. This guide stays up as the record of who was there. See upcoming conferences
Johnson & Johnson at ACR Convergence 2026
Nov 6–11, 2026 Orlando, FL ~15k attendees Website
Johnson & Johnson brings 12 presentations to ACR Convergence 2026 in Orlando, and exhibits at Booth 3228. Its program centres on psoriatic arthritis, with guselkumab trial results, treatment persistence and a discussion of axial involvement. It also covers Sjögren's disease, including nipocalimab, healthcare use and mortality in Swedish population studies.
| Organization | ACR Convergence 2026 Attendance |
|---|---|
Johnson & Johnson New Brunswick, NJ | |
A healthcare company with pharmaceutical and medical-device businesses. | Booth Exhibiting at Booth 3228 Sun, Nov 810:00am–5:00pmMon, Nov 910:00am–5:00pmTue, Nov 1010:00am–2:30pm Industry Sun Nov 8 12:30pm–1:15pm Managing Active PsA Across Multiple Key Domains: A Clinical Discussion on Axial Involvement Talk Mon Nov 9 9:00am–9:15am Poster Mon Nov 9 10:30am–12:30pm Poster Mon Nov 9 10:30am–12:30pm Poster Mon Nov 9 10:30am–12:30pm Poster Mon Nov 9 10:30am–12:30pm Poster Mon Nov 9 10:30am–12:30pm Poster Mon Nov 9 10:30am–12:30pm Poster Mon Nov 9 10:30am–12:30pm Poster Tue Nov 10 10:30am–12:30pm Poster Tue Nov 10 10:30am–12:30pm |
Find decision makers at Johnson & Johnson
Tell us what you sell and we’ll find the people at Johnson & Johnson most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the American College of Rheumatology (ACR). Organization details are derived from the ACR’s published program and exhibitor floor plan, and each organization’s own website. Submit a correction